Alerts will be sent to your verified email
Verify EmailKREBSBIO
Krebs Biochem.&Inds
|
Abbott India
|
Lincoln Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
81.16 % | 26.29 % | 16.41 % |
5yr average Equity Multiplier
|
-4.67 | 1.46 | 1.35 |
5yr Average Asset Turnover Ratio
|
0.31 | 1.18 | 0.87 |
5yr Avg Net Profit Margin
|
-60.54 % | 15.35 % | 14.05 % |
Price to Book
|
0.0 | 17.68 | 2.19 |
P/E
|
0.0 | 47.98 | 13.72 |
5yr Avg Cash Conversion Cycle
|
-241.81 Days | -44.73 Days | 10.4 Days |
Inventory Days
|
115.5 Days | 51.2 Days | 41.92 Days |
Days Receivable
|
4.91 Days | 20.12 Days | 86.41 Days |
Days Payable
|
243.79 Days | 107.05 Days | 100.81 Days |
5yr Average Interest Coverage Ratio
|
-4.81 | 119.35 | 44.62 |
5yr Avg ROCE
|
-22.64 % | 34.73 % | 20.85 % |
5yr Avg Operating Profit Margin
|
-37.97 % | 22.64 % | 21.16 % |
5 yr average Debt to Equity
|
-2.55 | 0.0 | 0.03 |
5yr CAGR Net Profit
|
4.02 % | 16.09 % | 8.4 % |
5yr Average Return on Assets
|
-18.18 % | 18.03 % | 12.15 % |
Shareholdings
|
|||
Promoter Holding
|
72.74 % | 74.99 % | 49.53 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
2.69 % | 0.0 | 12.27 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 4.35 % | 0.0 |
Krebs Biochem.&Inds
|
Abbott India
|
Lincoln Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|